Cargando…
Pingyangmycin inhibits glycosaminoglycan sulphation in both cancer cells and tumour tissues
Pingyangmycin is a clinically used anticancer drug and induces lung fibrosis in certain cancer patients. We previously reported that the negatively charged cell surface glycosaminoglycans are involved in the cellular uptake of the positively charged pingyangmycin. However, it is unknown if pingyangm...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131950/ https://www.ncbi.nlm.nih.gov/pubmed/32068946 http://dx.doi.org/10.1111/jcmm.15017 |